Hemilä Harri
Department of Public Health, POB 20 University of Helsinki, Tukholmankatu 8 B, FI-00014, Helsinki, Finland.
BMC Med Res Methodol. 2017 May 12;17(1):82. doi: 10.1186/s12874-017-0356-y.
The relative scale has been used for decades in analysing binary data in epidemiology. In contrast, there has been a long tradition of carrying out meta-analyses of continuous outcomes on the absolute, original measurement, scale. The biological rationale for using the relative scale in the analysis of binary outcomes is that it adjusts for baseline variations; however, similar baseline variations can occur in continuous outcomes and relative effect scale may therefore be often useful also for continuous outcomes. The aim of this study was to determine whether the relative scale is more consistent with empirical data on treating the common cold than the absolute scale.
Individual patient data was available for 2 randomized trials on zinc lozenges for the treatment of the common cold. Mossad (Ann Intern Med 125:81-8, 1996) found 4.0 days and 43% reduction, and Petrus (Curr Ther Res 59:595-607, 1998) found 1.77 days and 25% reduction, in the duration of colds. In both trials, variance in the placebo group was significantly greater than in the zinc lozenge group. The effect estimates were applied to the common cold distributions of the placebo groups, and the resulting distributions were compared with the actual zinc lozenge group distributions.
When the absolute effect estimates, 4.0 and 1.77 days, were applied to the placebo group common cold distributions, negative and zero (i.e., impossible) cold durations were predicted, and the high level variance remained. In contrast, when the relative effect estimates, 43 and 25%, were applied, impossible common cold durations were not predicted in the placebo groups, and the cold distributions became similar to those of the zinc lozenge groups.
For some continuous outcomes, such as the duration of illness and the duration of hospital stay, the relative scale leads to a more informative statistical analysis and more effective communication of the study findings. The transformation of continuous data to the relative scale is simple with a spreadsheet program, after which the relative scale data can be analysed using standard meta-analysis software. The option for the analysis of relative effects of continuous outcomes directly from the original data should be implemented in standard meta-analysis programs.
相对量表在流行病学二元数据的分析中已使用数十年。相比之下,对连续性结局进行荟萃分析一直以来都基于绝对的原始测量量表。在二元结局分析中使用相对量表的生物学原理是它能对基线差异进行调整;然而,连续性结局中也可能出现类似的基线差异,因此相对效应量表对于连续性结局也可能常常有用。本研究的目的是确定在治疗普通感冒方面,相对量表是否比绝对量表更符合实证数据。
有两项关于锌含片治疗普通感冒的随机试验的个体患者数据。莫萨德(《内科学年鉴》125:81 - 8, 1996)发现感冒持续时间缩短了4.0天,降幅为43%,彼得鲁斯(《当前治疗研究》59:595 - 607, 1998)发现感冒持续时间缩短了1.77天,降幅为25%。在两项试验中,安慰剂组的方差均显著大于锌含片组。将效应估计值应用于安慰剂组的普通感冒分布情况,并将所得分布与实际的锌含片组分布进行比较。
当将绝对效应估计值4.0天和1.77天应用于安慰剂组的普通感冒分布时,预测出了负的和零(即不可能)的感冒持续时间,且高方差依然存在。相比之下,当应用相对效应估计值43%和25%时,安慰剂组未预测出不可能的普通感冒持续时间,且感冒分布变得与锌含片组的分布相似。
对于一些连续性结局,如疾病持续时间和住院时间,相对量表能带来更具信息量的统计分析以及对研究结果更有效的传达。使用电子表格程序可轻松将连续性数据转换为相对量表,之后可使用标准的荟萃分析软件对相对量表数据进行分析。标准的荟萃分析程序应具备直接从原始数据分析连续性结局相对效应的选项。